2022
From cohorts to molecules: Adverse impacts of endocrine disrupting mixtures.
2021
The mammalian ovary: Concerns about the evaluation of prenatal environmental exposures.
The insulin-like growth factor system: A target for endocrine disruptors?
A pragmatic approach to Adverse Outcome Pathways (AOP) development and evaluation.
Six decades of research on human fetal gonadal steroids.
2020
Safeguarding female reproductive health against endocrine disrupting chemicals – the FREIA project.
Dynamics of the transcriptional landscape during human fetal testis and ovary development.